Another big pharma in show of faith in 'big data'

11 September 2017

German life sciences company Merck KGaA (MRK: DE) on Sunday became the latest pharma major to back the big data revolution that some believe will transform healthcare.

The company will enter into a strategic collaboration with Project Data Sphere, an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium, to jointly lead the Global Oncology Big Data Alliance (GOBDA).

"We are excited about the GOBDA initiative and the continuing engagement of a diverse community focused on finding solutions for cancer patients"

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK